Los fondos del OHSU Knight Cancer Institute aumentarán los programas de supervivencia al cáncer y las pruebas de detección de cáncer de cuello uterino, entre otras iniciativas.
El Legado Dorothy and Eric Lemelson para Extensión Comunitaria respaldará subvenciones para responder a problemas de cáncer identificados por la comunidad, desigualdades de salud.
The Dorothy and Eric Lemelson Endowment for Community Outreach will support grants to respond to community-identified cancer issues, health disparities.
El Dr. Ramón Barajas, Jr. y la Dra. Haijiao Zhang son dos de los 11 galardonados en todo el país; sus 6.5 millones de dólares en financiación total abordarán las necesidades urgentes en el tratamiento del cáncer cerebral y de la sangre.
Ramon Barajas, Jr., M.D., and Haijiao Zhang, M.D., are two of 11 awardees nationwide; their $6.5 million in total funding will address urgent needs in brain, blood cancer treatment.
El Community Partnership Program financia una diversidad de ideas generadas en la comunidad para atender la carga que representa el cáncer en todo el estado.
Los/las profesionales médicos/as de OHSU que realizan más de 550 exámenes de piel gratuitos en todo Oregón organizarán eventos de exámenes de piel gratis el 20 y 21 de mayo en OHSU.
El instituto financia 11 iniciativas locales, incluido un programa para dejar de fumar orientado a adolescentes, trabajo para prevenir el cáncer a través de la alfabetización en salud y la evaluación de regiones con inseguridad alimentaria.
Institute funds 11 local efforts, including teen tobacco cessation program, work to prevent cancer through health literacy, assessment of food insecurity.
Según directivos de OHSU, la donación del patrimonio de George y Helene Ettelson será un “recurso vital” para innovar en materia de investigación en atención médica.
Una paciente con cáncer de mama avanzado, portadora de mutación genómica muy poco frecuente, se beneficia con un ensayo clínico en etapa inicial de Oregon Health & Science University.
Los proyectos incluyen iniciativas para incrementar las tasas de pruebas de detección de cáncer cervical, facilitar un grupo de apoyo para padres de pacientes pediátricos con cáncer, mejorar el índice de pacientes que se someten a pruebas de detección de cáncer colorrectal y más.
Projects include efforts to increase cervical cancer screening rates, foster a support group for parents of pediatric cancer patients, improve colorectal cancer screening, and more.
Nueva camioneta de extensión comunitaria del Knight Cancer Institute de OHSU lleva información y recursos de prevención a las personas de todo el estado.
Guinness World Records reconoce al equipo que confirmó el cáncer de piel más pequeño del mundo; el equipo directivo de OHSU enfatiza la importancia de la detección temprana del cáncer.
Guinness World Records recognizes the team that verified the world’s smallest skin cancer, OHSU leaders emphasize the importance of early cancer detection.
OHSU encabeza un estudio de alcance nacional para averiguar en qué afectó la pandemia las conversaciones de los pacientes con respecto al uso de tabaco, financiado en parte por la iniciativa Cancer MoonshotSM del National Cancer Institute.
OHSU leads national study on how pandemic affected patient discussions about tobacco use; funded in part by the National Cancer Institute’s Cancer Moonshot initiative.
NIH-backed projects will help accelerate the use of artificial intelligence, machine learning to tackle complex research challenges for cancer, other diseases.
Newly funded projects will focus on needs of Spanish-speaking communities, measure impact of financial support during cancer treatment, provide youth peer education for HPV prevention.
New study co-led by OHSU researchers provides most robust U.S. estimate to date, shows overdiagnosis not as ‘alarmingly frequent’ as commonly believed.
As a member of the OHSU Knight Cancer Network, Saint Alphonsus will help expand cancer research, clinical trial opportunities, advanced specialized care to patients.
Together with collaborators in the U.S. and U.K., the OHSU Knight Cancer Institute launches new alliance solely focused on the early detection of cancer.
May 18 event will mark the launch of a statewide public awareness campaign to help educate the public about the importance of skin cancer screening, early detection.
OHSU’s Center for Health & Healing Building 2 and the Gary & Christine Rood Family Pavilion offer an innovative approach to patient and family experience.
By acquiring OHSU's MolecularMD, the clinical research organization ICON, based in Dublin, Ireland, has expanded its laboratory offering in molecular diagnostic testing and brings expanded testing platforms.
Newly funded projects include the Asian Health & Service Center, which received a grant to help increase culturally and linguistically appropriate cancer resources for Asian communities in Oregon.
Annual community event will offer free skin cancer exams, samples and services from skin care professionals, and a 5K Walk or Fun Run to benefit melanoma research.
Knight Cancer Institute associate director for basic research reflects on building labs, challenging dogma, and dedicating her life to impacting cancer research.
Pacific Northwest National Laboratory and OHSU today announced a joint collaboration to improve patient care by focusing research on highly complex sets of biomedical data, and the tools to interpret them.
OHSU is the first in the nation to implement a virtual simulation tool into its clinical care program, allowing patients to see, hear and understand what treatment will be like.
The first FDA-approved gene transfer therapy for patients with acute lymphoblastic leukemia will be available at a handful of approved hospitals, including OHSU Doernbecher.
A new study focused on the research and development spending of some pharmaceutical companies found the cost of bringing a cancer drug to market was significantly less than previously reported.
OHSU will collaborate with other other teams to establish a pediatric cancer and rare disease data program--a first for the pediatric research community.
The Office of Cancer Clinical Proteomics Research (OCCPR) at the National Cancer Institute (NCI) announced the institutes that will comprise the Proteogenomic Translational Research Centers, a group created to collaborate with NCI-sponsored clinical trials.
Today the OHSU Knight Cancer Institute announced that internationally renowned bioengineering and technology expert Mike Heller, Ph.D., will join the institute’s Cancer Early Detection Advanced Research Center, or CEDAR, to lead its technology efforts.
A study of more than 500 cancer survivors found that many years after completing treatment, nearly half of women cancer survivors continued to experience chemotherapy-induced peripheral neuropathy, CIPN.
“Despite everything I’ve been through, in some ways, I’m in the best shape of my life now, as a cancer survivor,” says Joe Heiden, a competitor on the television program "American Ninja Warrior."
The National Cancer Institute has awarded a research team at the OHSU Knight Cancer Institute $9.2 million over five years to serve as a Research Center in the NCI’s Cancer Systems Biology Consortium, or CSBC.